Alterations in fatty acid composition of plasma and erythrocyte lipids in critically III patients during sepsis;Změny ve složzení mastných kyselin v lipidech plazmy a erytrocytů u kriticky nemocných v průbéhu sepse

Casopis Lekaru Ceskych

Volumn 149, Issue 7, 2010, Pages 324-331

  Novák, František ^a   Borovská, Jiřina ^a   Vecka, Marek ^a   Vávrová, Lucie ^a   Kodydková, Jana ^a   Mráčkova, Magdaléna ^a   Novák Sr , Frahtišek ^a,b   Noyáková, Olgai ^a   Žák, Aleš ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Centrum kardiovaskulárniho výzkumu   (Czech Republic)

Author keywords

C reactive protein; Critical care; Fatty acids of erythrocyte phospholipids; Fatty acids of plasma lipids; n 3 PUFA; n 6 PUFA; Sepsis

Indexed keywords

FATTY ACID; LIPID; OMEGA 3 FATTY ACID;

AGED; ARTICLE; BLOOD; CRITICAL ILLNESS; ERYTHROCYTE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PLASMA; SEPSIS; SURVIVAL RATE;

AGED; CRITICAL ILLNESS; ERYTHROCYTES; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PLASMA; SEPSIS; SURVIVAL RATE;

EID: 77955672396     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Cook HW, McMaster ChR. Fatty acid desaturation and chain elongation in eukaryotes. In: Vance DE, Vance JE, eds. Biochemistry of lipids, lipoproteins and membranes. 4th Ed. Amsterdam: Elsevier 2002; 181-204.
2. Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 2006; 1: 420-439.
3. Arterburn LM, et al. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006; 83: 1467S-1476S.
4. Smith WL, Murphy RC. The eicosanoids: cyclooxygenase, lipoxygenase and epoxygenase pathways. In: Vance DE, Vance JE, eds. Biochemistry of lipids, lipoproteins and membranes. 4th Ed. Amsterdam: Elsevier 2002; 341-369.
5. Harris SG, et al. Prostaglandins as modulators of immunity. Trends Immunol 2002; 23: 144-150.
6. Lewis RA, et al. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990; 323: 645-655.
7. Tilley SL, et al. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001; 108: 15-23.
8. Levy BD, et al. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2001; 2: 612-619.
9. Pontes-Arruda A, deMichele SJ. Enteral nutrition with antiinflammatory lipids in ALI/ARDS. In: Vincent JL, ed. Yearbook of intensive care and emergency medicine 2009. Berlin: Springer-Verlag 2009; 695-704.
10. Obata T, et al. Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. Clin Exp Allergy 1999; 29: 1129-1135.
11. Calder PC. Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Braz J Med Biol Res 2003; 36: 433-446.
12. Brandt S, et al. The role of hypoxia and inflammation in the expression and regulation of proteins regulating iron metabolism. In: Vincent JL, ed. Yearbook of intensive care and emergency medicine 2008. Berlin: Springer-Verlag 2008; 473-480.
13. Forceville X, van Anterpen P. Selenocompounds and selenium: a biochemical approach to sepsis. In: Vincent JL, ed. Yearbook of intensive care and emergency medicine 2008. Berlin: Springer-Verlag 2008; 454-469.
14. Halliwell B, Gutteridge JM. Free radicals in biology and medicine. 4th Ed. Oxford: Oxford University Press 2007.
15. Barton RG. Nutrition support in critical illness. Nutr Clin Pract 1994; 9: 127-139.
16. Wolfe RR, et al. Energy metabolism in trauma and sepsis: the role of fat. Prog Clin Biol Res 1983; 111: 89-109.
17. Wolfe RR, et al. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 1987; 317: 403-408.
18. Kumar KV, et al. Oxidant stress and essential fatty acids in patients with risk and established ARDS. Clin Chim Acta 2000; 298: 111-120.
19. Prabha PS, et al. Free radical generation, lipid peroxidation and essential fatty acids in patients with septicemia. Prostaglandins Leukot Essent Fatty Acids 1991; 42: 61-65.
20. Pratt VC, et al. Fatty acid content of plasma lipids and erythrocyte phospholipids are altered following burn injury. Lipids 2001; 36: 675-682.
21. Zamaria N. Alteration of polyunsaturated fatty acid status and metabolism in health and disease. Reprod Nutr Dev 2004; 44: 273-282.
22. Berquin IM, et al. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 2008; 269: 363-377.
23. Imre SG, et al. Increased proportion of docosahexanoic acid and high lipid peroxidation capacity in erythrocytes of stroke patients. Stroke 1994; 25: 2416-2420.
24. Lemaitre RN, et al. Red blood cell membrane alpha-linolenic acid and the risk of sudden cardiac arrest. Metabolism 2009; 58: 534-540.
25. Rodrigo R, et al. Relationship between (Na + K)-ATPase activity, lipid peroxidation and fatty acid profile in erythrocytes of hypertensive and normotensive subjects. Mol Cell Biochem 2007; 303: 73-81.
26. Santos MJ, et al. Influence of dietary fish on fatty acid composition of the erythrocyte membrane in coronary heart disease patients. Int J Vitam Nutr Res 1996; 66: 378-385.
27. Ueda Y, et al. Elevated concentrations of linoleic acid in erythrocyte membrane phospholipids in patients with inflammatory bowel disease. Nutr Res 2008; 28: 239-244.
28. Bone RC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
29. Knaus WA, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
30. Kreymann KG, et al. ESPEN Guidelines on Enteral Nutrition: Intensive care. Clin Nutr 2006; 25: 210-223.
31. Folch J, et al. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497-509.
32. Tvrzická E, et al. Analysis of fatty acids in plasma lipoproteins by gas chromatography-flame ionization detection. Quantitative aspects. Anal Chim Acta 2002; 465: 337-350.
33. Rose HG, Oklander M. Improved procedure for the extraction of lipids from human erythrocytes. J Lipid Res 1965; 6: 428-431.
34. Riccardi G, et al. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 2004; 23: 447-456.
35. Warensjo E, et al. Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am J Clin Nutr 2006; 84: 442-448.
36. Yazu K, et al. Mechanism of lower oxidizability of eicosapentaenoate than linoleate in aqueous micelles. Lipids 1996;31:337-340.
37. Quinlan GJ, et al. Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome. Crit Care Med 1996; 24: 241-246.
38. Goodyear-Bruch C, et al. Oxidative stress in critically ill patients. Am J Crit Care 2002; 11: 543-551.
39. Gutteridge JM, et al. Redox imbalance in the critically ill. Br Med Bull 1999;55:49-75.
40. Nakamura MT, et al. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu Rev Nutr 2004; 24: 345-376.
41. Biddinger SB, et al. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c. Diabetes 2006; 55: 2032-2041.